[go: up one dir, main page]

RU2018145808A3 - - Google Patents

Download PDF

Info

Publication number
RU2018145808A3
RU2018145808A3 RU2018145808A RU2018145808A RU2018145808A3 RU 2018145808 A3 RU2018145808 A3 RU 2018145808A3 RU 2018145808 A RU2018145808 A RU 2018145808A RU 2018145808 A RU2018145808 A RU 2018145808A RU 2018145808 A3 RU2018145808 A3 RU 2018145808A3
Authority
RU
Russia
Application number
RU2018145808A
Other versions
RU2738207C2 (ru
RU2018145808A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018145808A3 publication Critical patent/RU2018145808A3/ru
Publication of RU2018145808A publication Critical patent/RU2018145808A/ru
Application granted granted Critical
Publication of RU2738207C2 publication Critical patent/RU2738207C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RU2018145808A 2016-06-07 2017-06-06 Производное фенилпропанамида, способ его получения и его фармацевтическое применение RU2738207C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610397516 2016-06-07
CN201610397516.3 2016-06-07
PCT/CN2017/087328 WO2017211272A1 (zh) 2016-06-07 2017-06-06 苯基丙酰胺类衍生物、其制备方法及其在医药上的应用

Publications (3)

Publication Number Publication Date
RU2018145808A3 true RU2018145808A3 (ru) 2020-07-09
RU2018145808A RU2018145808A (ru) 2020-07-09
RU2738207C2 RU2738207C2 (ru) 2020-12-09

Family

ID=60578399

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018145808A RU2738207C2 (ru) 2016-06-07 2017-06-06 Производное фенилпропанамида, способ его получения и его фармацевтическое применение

Country Status (13)

Country Link
US (1) US20190144499A1 (ru)
EP (1) EP3466962A4 (ru)
JP (1) JP7120927B2 (ru)
KR (1) KR102401743B1 (ru)
CN (3) CN114940700A (ru)
AU (1) AU2017277003B2 (ru)
BR (1) BR112018074431A2 (ru)
CA (1) CA3025710A1 (ru)
MX (1) MX2018015082A (ru)
RU (1) RU2738207C2 (ru)
TW (1) TWI781938B (ru)
UA (1) UA123737C2 (ru)
WO (1) WO2017211272A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3466962A4 (en) * 2016-06-07 2020-01-08 Jiangsu Hengrui Medicine Co., Ltd. PHENYLPROPANAMIDE DERIVATIVE AND MANUFACTURING METHOD AND PHARMACEUTICAL APPLICATION THEREOF
WO2018059331A1 (zh) * 2016-09-27 2018-04-05 四川科伦博泰生物医药股份有限公司 多酰胺化合物及其用途
CN109879934B (zh) * 2017-12-06 2020-12-08 江苏恒瑞医药股份有限公司 一种苯基丙酰胺类衍生物的盐及其制备方法
US11471503B2 (en) 2017-12-06 2022-10-18 Jiangsu Hengrui Medicine Co., Ltd. Use of KOR agonist in combination with MOR agonist in preparing drug for treating pain
JP2021505596A (ja) * 2017-12-06 2021-02-18 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司Jiangsu Hengrui Medicine Co., Ltd. フェニルプロピオンアミド誘導体の塩およびその製造方法
KR20210010490A (ko) * 2018-05-16 2021-01-27 지앙수 헨그루이 메디슨 컴퍼니 리미티드 Kor 수용체 작용제의 약학적 조성물
WO2021026492A1 (en) 2019-08-07 2021-02-11 Humanwell Pharmaceutical US Kappa opioid receptor peptide amide agonists
CN110790817A (zh) 2019-11-12 2020-02-14 成都诺和晟泰生物科技有限公司 一种多肽类化合物、制剂、药物组合物及制备方法、应用
CN113493490B (zh) * 2020-04-03 2024-03-12 成都诺和晟泰生物科技有限公司 一种合成肽酰胺类化合物及其在医药领域的用途
EP4144750A4 (en) * 2020-04-30 2024-05-22 Medshine Discovery Inc. Phenylpropionamide compound and use thereof
AU2020454871A1 (en) 2020-06-25 2023-01-19 Humanwell Pharmaceutical US Peptides for treatment of medical disorders
FR3114739B1 (fr) * 2020-10-06 2022-08-26 Centre Nat Rech Scient Nouveaux peptoides et leur utilisation dans la prevention ou le traitement de la douleur chronique
CN115925699B (zh) * 2022-02-25 2023-10-03 南京知和医药科技有限公司 具有镇痛活性的稠环化合物及其制备方法与用途
TWI888808B (zh) 2022-03-23 2025-07-01 大陸商江蘇恩華藥業股份有限公司 多醯胺類化合物、其製備方法及其醫藥用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236766B2 (en) * 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7402564B1 (en) * 2006-11-10 2008-07-22 Cara Therapeutics, Inc. Synthetic peptide amides
US8906859B2 (en) * 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
CA2727573A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
WO2010006267A2 (en) * 2008-07-11 2010-01-14 University Of Kansas Cyclic tetrapeptides
WO2010105636A1 (en) * 2009-03-17 2010-09-23 United Technologies Ut Ag Topical compositions comprising interleukin-1 alpha and peptides and cosmetic methods thereof
CN104271552B (zh) * 2012-03-05 2017-08-08 雷迪博士实验室有限公司 作为kappa阿片样物质受体(kor)激动剂的取代的杂环乙酰胺
WO2013184794A2 (en) * 2012-06-05 2013-12-12 Cara Therapeutics, Inc. Peripheral kappa receptor agonists for reducing pain and inflammation
WO2014089019A1 (en) * 2012-12-03 2014-06-12 University Of Washington Through Its Center For Commercialization Methods and compositions for treating vasomotor symptoms
WO2014184356A1 (en) * 2013-05-17 2014-11-20 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Perhydroquinoxaline derivatives useful as analgesics
WO2015065867A2 (en) * 2013-10-28 2015-05-07 Cara Therapeutics, Inc. Peripheral kappa opioid receptor agonists for preventing, inhibiting or treating nausea and vomiting
CN105523996B (zh) * 2014-10-17 2020-03-06 江苏恒瑞医药股份有限公司 酰胺类衍生物、其制备方法及其在医药上的应用
EP3466962A4 (en) * 2016-06-07 2020-01-08 Jiangsu Hengrui Medicine Co., Ltd. PHENYLPROPANAMIDE DERIVATIVE AND MANUFACTURING METHOD AND PHARMACEUTICAL APPLICATION THEREOF

Also Published As

Publication number Publication date
CN114940700A (zh) 2022-08-26
RU2738207C2 (ru) 2020-12-09
TW201742858A (zh) 2017-12-16
HK1255567A1 (zh) 2019-08-23
WO2017211272A1 (zh) 2017-12-14
AU2017277003B2 (en) 2021-01-07
AU2017277003A1 (en) 2018-12-13
JP7120927B2 (ja) 2022-08-17
MX2018015082A (es) 2019-04-22
BR112018074431A2 (pt) 2019-03-06
RU2018145808A (ru) 2020-07-09
UA123737C2 (uk) 2021-05-26
TWI781938B (zh) 2022-11-01
KR20190016516A (ko) 2019-02-18
CN108290926B (zh) 2022-02-08
KR102401743B1 (ko) 2022-05-24
JP2019517530A (ja) 2019-06-24
CN108290926A (zh) 2018-07-17
US20190144499A1 (en) 2019-05-16
EP3466962A4 (en) 2020-01-08
EP3466962A1 (en) 2019-04-10
CA3025710A1 (en) 2017-12-14
CN114349820A (zh) 2022-04-15

Similar Documents

Publication Publication Date Title
BR112019001667A2 (ru)
BR212018070320U2 (ru)
BR112018071172A2 (ru)
BE2016C036I2 (ru)
BE2016C010I2 (ru)
CN303580024S (ru)
CN303535546S (ru)
CN303659321S (ru)
CN303654920S (ru)
CN303535544S (ru)
BY21942C1 (ru)
CN303647795S (ru)
CN303646552S (ru)
CN303690231S (ru)
CN303536130S (ru)
CN303627640S (ru)
CN303612431S (ru)
CN303608296S (ru)
CN303575563S (ru)
CN303589811S (ru)
CN303536239S (ru)
CN303536049S (ru)
CN303537400S (ru)
CN303586662S (ru)
CN303537760S (ru)